Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer ModelingJuliann Chmielecki, William Pao, Kadoaki Ohashi et al.|Science Translational Medicine|2011Cited by 530
Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) BlockadeJuan C. Osorio, Matthew D. Hellmann, Kathryn C. Arbour et al.|Journal of Clinical Oncology|2019Cited by 134